326 related articles for article (PubMed ID: 24776844)
1. Associations between functional polymorphisms in the NFκB signaling pathway and response to anti-TNF treatment in Danish patients with inflammatory bowel disease.
Bank S; Andersen PS; Burisch J; Pedersen N; Roug S; Galsgaard J; Turino SY; Brodersen JB; Rashid S; Rasmussen BK; Avlund S; Olesen TB; Hoffmann HJ; Thomsen MK; Thomsen VØ; Frydenberg M; Nexø BA; Sode J; Vogel U; Andersen V
Pharmacogenomics J; 2014 Dec; 14(6):526-34. PubMed ID: 24776844
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel disease.
Bank S; Julsgaard M; Abed OK; Burisch J; Broder Brodersen J; Pedersen NK; Gouliaev A; Ajan R; Nytoft Rasmussen D; Honore Grauslund C; Roug S; Galsgaard J; Sprogøe Høyer Finsen D; Lindby K; ; Sørensen J; Larsen L; Rohr Andersen M; Brandslund I; Thomassen M; Green A; Bo Bojesen A; Bek Sørensen S; Vogel U; Andersen V
Aliment Pharmacol Ther; 2019 Apr; 49(7):890-903. PubMed ID: 30811631
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the inflammatory pathway genes TLR2, TLR4, TLR9, LY96, NFKBIA, NFKB1, TNFA, TNFRSF1A, IL6R, IL10, IL23R, PTPN22, and PPARG are associated with susceptibility of inflammatory bowel disease in a Danish cohort.
Bank S; Skytt Andersen P; Burisch J; Pedersen N; Roug S; Galsgaard J; Ydegaard Turino S; Brodersen JB; Rashid S; Kaiser Rasmussen B; Avlund S; Bastholm Olesen T; Jürgen Hoffmann H; Kragh Thomsen M; Ostergaard Thomsen V; Frydenberg M; Andersen Nexø B; Sode J; Vogel U; Andersen V
PLoS One; 2014; 9(6):e98815. PubMed ID: 24971461
[TBL] [Abstract][Full Text] [Related]
4. Systematic review: genetic biomarkers associated with anti-TNF treatment response in inflammatory bowel diseases.
Bek S; Nielsen JV; Bojesen AB; Franke A; Bank S; Vogel U; Andersen V
Aliment Pharmacol Ther; 2016 Sep; 44(6):554-67. PubMed ID: 27417569
[TBL] [Abstract][Full Text] [Related]
5. Genetically determined high activity of IL-12 and IL-18 in ulcerative colitis and TLR5 in Crohns disease were associated with non-response to anti-TNF therapy.
Bank S; Andersen PS; Burisch J; Pedersen N; Roug S; Galsgaard J; Turino SY; Brodersen JB; Rashid S; Rasmussen BK; Avlund S; Olesen TB; Hoffmann HJ; Nexø BA; Sode J; Vogel U; Andersen V
Pharmacogenomics J; 2018 Jan; 18(1):87-97. PubMed ID: 28139755
[TBL] [Abstract][Full Text] [Related]
6. Genetically determined high activities of the TNF-alpha, IL23/IL17, and NFkB pathways were associated with increased risk of ankylosing spondylitis.
Sode J; Bank S; Vogel U; Andersen PS; Sørensen SB; Bojesen AB; Andersen MR; Brandslund I; Dessau RB; Hoffmann HJ; Glintborg B; Hetland ML; Locht H; Heegaard NH; Andersen V
BMC Med Genet; 2018 Sep; 19(1):165. PubMed ID: 30208882
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of anti-tumour necrosis factor-α therapy in Danish patients with inflammatory bowel diseases.
Bank S; Andersen PS; Burisch J; Pedersen N; Roug S; Galsgaard J; Turino SY; Brodersen JB; Rashid S; Avlund S; Olesen TB; Green A; Hoffmann HJ; Thomsen MK; Thomsen VØ; Nexø BA; Vogel U; Andersen V
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748864
[TBL] [Abstract][Full Text] [Related]
8. Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasis.
Loft ND; Skov L; Iversen L; Gniadecki R; Dam TN; Brandslund I; Hoffmann HJ; Andersen MR; Dessau RB; Bergmann AC; Andersen NM; Andersen PS; Bank S; Vogel U; Andersen V
Pharmacogenomics J; 2018 May; 18(3):494-500. PubMed ID: 28696418
[TBL] [Abstract][Full Text] [Related]
9. Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF{kappa}B signalling pathways.
Potter C; Cordell HJ; Barton A; Daly AK; Hyrich KL; Mann DA; Morgan AW; Wilson AG; ; Isaacs JD
Ann Rheum Dis; 2010 Jul; 69(7):1315-20. PubMed ID: 20448286
[TBL] [Abstract][Full Text] [Related]
10. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
[TBL] [Abstract][Full Text] [Related]
11. TNF-α-induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade-driven IL-17A expression.
Urbano PCM; Aguirre-Gamboa R; Ashikov A; van Heeswijk B; Krippner-Heidenreich A; Tijssen H; Li Y; Azevedo VF; Smits LJT; Hoentjen F; Joosten I; Koenen HJPM
J Allergy Clin Immunol; 2018 Aug; 142(2):517-529. PubMed ID: 29248493
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms in C-type lectin genes, clustered in the IBD2 and IBD6 susceptibility loci, may play a role in the pathogenesis of inflammatory bowel diseases.
Wolfkamp SC; Verstege MI; Vogels EW; Meisner S; Verseijden C; Stokkers PC; te Velde AA
Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):965-70. PubMed ID: 22664939
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively.
Sashio H; Tamura K; Ito R; Yamamoto Y; Bamba H; Kosaka T; Fukui S; Sawada K; Fukuda Y; Tamura K; Satomi M; Shimoyama T; Furuyama J
Immunogenetics; 2002 Mar; 53(12):1020-7. PubMed ID: 11904678
[TBL] [Abstract][Full Text] [Related]
14. Interactions among genes influencing bacterial recognition increase IBD risk in a population-based New Zealand cohort.
Petermann I; Huebner C; Browning BL; Gearry RB; Barclay ML; Kennedy M; Roberts R; Shelling AN; Philpott M; Han DY; Ferguson LR
Hum Immunol; 2009 Jun; 70(6):440-6. PubMed ID: 19275920
[TBL] [Abstract][Full Text] [Related]
15. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
Cantor MJ; Nickerson P; Bernstein CN
Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort.
Bank S; Andersen PS; Burisch J; Pedersen N; Roug S; Galsgaard J; Ydegaard Turino S; Brodersen JB; Rashid S; Kaiser Rasmussen B; Avlund S; Bastholm Olesen T; Hoffmann HJ; Andersen Nexø B; Sode J; Vogel U; Andersen V
PLoS One; 2015; 10(12):e0145302. PubMed ID: 26698117
[TBL] [Abstract][Full Text] [Related]
17. Colonic Phenotypes Are Associated with Poorer Response to Anti-TNF Therapies in Patients with IBD.
Yoon SM; Haritunians T; Chhina S; Liu Z; Yang S; Landers C; Li D; Ye BD; Shih D; Vasiliauskas EA; Ippoliti A; Rabizadeh S; Targan SR; Melmed GY; McGovern DPB
Inflamm Bowel Dis; 2017 Aug; 23(8):1382-1393. PubMed ID: 28590340
[TBL] [Abstract][Full Text] [Related]
18. The Clinical Relevance of the IBD-Associated Variation within the Risk Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 2 in Patients of the Swiss IBD Cohort.
Spalinger MR; Voegelin M; Biedermann L; Zeitz J; Rossel JB; Sulz MC; Frei P; Scharl S; Vavricka SR; Fried M; Rogler G; Scharl M;
Digestion; 2016; 93(3):182-92. PubMed ID: 26928573
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease.
de Silva PS; Nguyen DD; Sauk J; Korzenik J; Yajnik V; Ananthakrishnan AN
Aliment Pharmacol Ther; 2012 Sep; 36(5):459-66. PubMed ID: 22784296
[TBL] [Abstract][Full Text] [Related]
20. A cohort of anti-TNF treated Danish patients with inflammatory bowel disease, used for identifying genetic markers associated with treatment response.
Bank S
Dan Med J; 2015 May; 62(5):. PubMed ID: 26050839
[No Abstract] [Full Text] [Related]
[Next] [New Search]
